EntuzityTM - Now covered by the Quebec Health Insurance Board (RAMQ)
2022-02-03
Insulin
Trurapi® - Now covered by the Quebec Health Insurance Board (RAMQ)
Complete list of biosimilars and RAMQ instructions for transition by April 13. (Info RAMQ) (see Continuing
Education/Presentation Archives/Training on biosimilars tab for more information)
Baqsimi is Now Listed on the Régie de l'assurance maladie du Québec (RAMQ*). The cost of Baqsimi is covered under the general plan only for people receiving insulin. (Info RAMQ) Also Baqsimi is now reimbursed by all federal benefit programs, including
the Non-Insured Health Benefits (NIHB) program, Veterans Affairs Canada (VAC) and Correctional Services Canada (CSC) (see Resources/Education/Glucagon/Baqsimi tab for more information)
2021-12-18
CLASSES
Forxiga® (Dapagliflozin) is now covered by the RAMQ: Code CV399 for the treatment of people with class II or III heart failure
for adults with or without diabetes who present with left ventricular systolic dysfunction (with ejection fraction ≤ 40%) and who have been receiving an ACEI or ARB for at least 4 weeks in combination with a beta-blocker, unless
there is a contraindication or intolerance.
Jardiance® - New Health Canada Approval : Is indicated in adults with or without type 2 diabetes for the treatment of heart failure with reduced ejection
fraction (Monograph).
New indication in Chronic Kidney Disease for FORXIGA. Indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular and renal death in adults with chronic kidney disease
(CKD). AND
FORXIGA is not recommended in patients with an eGFR less than 25 mL/min/1.73m2. On dialysis FORXIGA is contraindicated in patients on dialysis
2021-07-19
RAMQ Reimbursement
As of July 7, 2021 -With the exceptions provided for in this regulation, as of July 7, 2021, patients who are covered by the public drug insurance plan for a reference biologic drug will have until April 12,
2022 inclusive to switch to the biosimilar drug (See Attached Infolettre RAMQ)
Replacement of insuline lispro U100 (Humalog®) from Lilly to lispro U100 biosimilar (Admelog®) from Sanofi since march 3 2021 in Quebec (click on the link for more details)
Trulicity® - September 15 Health Canada gave a new indication for Trulicity: Indicated as an adjunct to diet, exercise, and standard of care therapy to reduce the
risk of nonfatal stroke in adults with type 2 diabetes mellitus who have multiple cardiovascular risk factors or established cardiovascular disease.
2020-08-25
Homepage
Tutorial video of the Diabetes Toolbox by the author
Classes + Insulin
Real size pictures of the molecules and pens - CLASSES + Insulin
2020-08-19
Insulin - Coverage
Tresiba®, Lantus® (Vial 10 ml), BasaglarMC, ToujeoMC and Levemir® now covered by the Quebec
Health Insurance Board (RAMQ) without exception. Novelties related to innovative medicines (fr)
2020-05-24
Resources
Injection Technic FIT Plus - Updating information
2020-04-26
Blood Glucose Monitoring - FreeStyle LibreTM
Modification to the recognized indication for the payment of Freestyle LibreMC
Forxiga® is now indicated as an adjunct to diet, exercise, and standard of care therapy to reduce the risk of hospitalization for heart failure in adults with type
2 diabetes mellitus and CV risk factors or established CV disease (see CLINICAL TRIALS).
Glargine U300 Toujeo® now covered by the Quebec Health Insurance Board (RAMQ) according to certain criteria
2019-08-04
Blood Glucose Monitoring
Update of the Intercative Guide
Update of the Comparison Charts (PDF)
2019-07-19
Coverage
The FreeStyle LibreTM glucose monitoring flash system is now covered by the Quebec Health Insurance Board (RAMQ) according to certain criteria (see Coverage or Blood Glucose Monitoring tab)
RAMQ Codes update (PDF)
2019-06-20
GLP-1RA
Semaglutide Ozempic® New 4 mg flextouch maintenance pen. The 2 mg pen for the maintenance dose is no longer available
2018-12-19
Coverage
RAMQ Codes update (PDF)
SynjardyTM now code EN219
2018-11-23
Coverage
Xigduo® and SynjardyTM now code EN150
2018-10-20
SGLT2
Adding - Ertugliflozin SteglatroTM
Adding - Ertugliflozin and Metformin SeglurometTM
Adding - Ertugliflozin and Sitagliptin SteglujanTM
Drug and Renal Function
New Chart Adjustment of the Medication with Renal Insufficiency
2018-10-01
Full update of the application
New
Addition of a search function
Overall improvement of performance and stability
Available soon for all Canadian provinces (in English only)
2018-09-27
Coverage
RAMQ Codes update (PDF) - Jardiance® now three codes EN148 - EN167 and EN179